SCHEMBL13428257

SCHEMBL13428257

c1cc(-c2ccc3ccccc3c2)cc(-c2c3ccc(N4CCCc5ccccc54)cc3c(-c3cccc(-c4ccc5ccccc5c4)c3)c3cc(N4CCCc5ccccc54)ccc23)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EED O75530 1/20 0.36
ROCK1 Q13464 1/20 0.36
JAK2 O60674 1/20 0.36
JAK3 P52333 1/20 0.36
PTK2 Q05397 1/20 0.36
AKT1 P31749 1/20 0.36
PIK3CA P42336 1/20 0.36
NUDT1 P36639 1/20 0.35
OPRM1 P35372 1/20 0.34
CYP11B1 P15538 1/20 0.34
RAB9A P51151 3/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
MAPT P10636 3/20 0.34
KDM4E B2RXH2 2/20 0.34
NPC1 O15118 2/20 0.34
ALDH1A1 P00352 2/20 0.34
HPGD P15428 2/20 0.34
TP53 P04637 2/20 0.34
MAPK1 P28482 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13426673 1.00 EED (0.36) EEDROCK1JAK2JAK3PTK2
SCHEMBL13426526 1.00 EED (0.36) EEDROCK1JAK2JAK3PTK2
SCHEMBL13426557 0.98 EED (0.35) EEDROCK1JAK2JAK3PTK2
SCHEMBL13426631 0.96 EED (0.36) EEDROCK1JAK2JAK3PTK2
SCHEMBL10010049 0.95 ROCK1 (0.39) EEDROCK1JAK2JAK3PTK2
SCHEMBL13428242 0.95 ROCK1 (0.39) EEDROCK1JAK2JAK3PTK2
SCHEMBL13426577 0.94 ROCK1 (0.37) EEDROCK1JAK2JAK3PTK2
SCHEMBL13426642 0.94 ROCK1 (0.37) EEDROCK1JAK2JAK3PTK2
SCHEMBL13428243 0.94 ROCK1 (0.37) EEDROCK1JAK2JAK3PTK2
SCHEMBL13426671 0.94 EED (0.35) EEDROCK1JAK2JAK3PTK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-04 US disclosed
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same RPL36, RPL39, RPL36A EED 1151/4885ROCK1 3925/4885JAK2 3180/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.